August 15, 2017 09:50 AM EDT
Pharma

Is Ama­zon plan­ning to dis­rupt the $560B pre­scrip­tion drug mar­ket?

John Carroll

Editor & Founder

All the buzz out of Ama­zon these days in­di­cates that the on­line jug­ger­naut is look­ing to dis­rupt the gi­ant US health­care mar­ket. And now …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Bris­tol My­ers, Ky­owa Kirin dis­close lay­offs

Am­gen an­nounces hold on Phase 1 obe­si­ty can­di­date, pipeline cuts

Eye­Point shares more mid-stage da­ta for ther­a­py try­ing to com­pete with Re­gen­eron's Eylea

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

GSK de­fi­ant against vac­cine chal­lenges, will pri­or­i­tize oth­er growth ar­eas

No­vo Nordisk is feel­ing the com­pe­ti­tion from com­pound­ed GLP-1s, ex­ec says

A service from the Financial Times